These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11697326)

  • 1. Five-chlorodeoxycytidine, a tumor-selective enzyme-driven radiosensitizer, effectively controls five advanced human tumors in nude mice.
    Greer S; Alvarez M; Mas M; Wozniak C; Arnold D; Knapinska A; Norris C; Burk R; Aller A; Dauphinée M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):791-806. PubMed ID: 11697326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation, pool size and incorporation studies in mice with 5-chloro-2'-deoxycytidine.
    Santos O; Perez LM; Briggle TV; Boothman DA; Greer SB
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):357-65. PubMed ID: 2394614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation.
    Greer S; Schwade J; Marion HS
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1059-69. PubMed ID: 7607927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked radiosensitization of cells in culture to X ray by 5-chlorodeoxycytidine coadministered with tetrahydrouridine, and inhibitors of pyrimidine biosynthesis.
    Perez LM; Mekras JA; Briggle TV; Greer S
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1453-8. PubMed ID: 6236189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice.
    Greer S; Santos O; Gottlieb C; Schwade J; Marion HS
    Int J Radiat Oncol Biol Phys; 1992; 22(3):505-10. PubMed ID: 1735688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.
    Greer S; Han T; Dieguez C; McLean N; Saer R; Reis I; Levi J; Marquez VE
    Anticancer Agents Med Chem; 2017; 17(2):250-264. PubMed ID: 27745548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization to X ray by 5-chloro-2'-deoxycytidine co-administered with tetrahydrouridine in several mammalian cell lines and studies of 2'-chloro derivatives.
    Perez LM; Greer S
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1523-7. PubMed ID: 3759575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Iododeoxyuridine increases the efficacy of the radioimmunotherapy of human tumors growing in nude mice.
    Santos O; Pant KD; Blank EW; Ceriani RL
    J Nucl Med; 1992 Aug; 33(8):1530-4. PubMed ID: 1634946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture.
    Boothman DA; Briggle TV; Greer S
    Mol Pharmacol; 1985 May; 27(5):584-94. PubMed ID: 2581125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Greer SB
    Cancer Res; 1985 Nov; 45(11 Pt 1):5270-80. PubMed ID: 2932216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
    Azria D; Coelho M; Larbouret C; Lemanski C; Serre A; Ychou M; Pèlegrin A; Dubois JB; Culine S
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S106-13. PubMed ID: 15679255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model.
    Joschko MA; Webster LK; Groves J; Yuen K; Palatsides M; Ball DL; Millward MJ
    Radiat Oncol Investig; 1997; 5(2):62-71. PubMed ID: 9303059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective radiosensitization and cytotoxicity of human melanoma cells using halogenated deoxycytidines and tetrahydrouridine.
    Lawrence TS; Davis MA
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1243-6. PubMed ID: 2715074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice.
    Chastagner P; Kozin SV; Taghian A
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):777-82. PubMed ID: 11395247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
    Sun LQ; Li YX; Guillou L; Coucke PA
    Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.